FKBP51 inhibition ameliorates neurodegeneration and motor dysfunction in the neuromelanin-SNCA mouse model of Parkinson's disease.
FKBP51 抑制可改善帕金森病神经黑色素-SNCA 小鼠模型中的神经退行性变和运动功能障碍
期刊:Molecular Therapy
影响因子:12
doi:10.1016/j.ymthe.2025.01.049
Garcia-Gomara Marta, Legarra-Marcos Naroa, Serena Maria, Rojas-de-Miguel Elvira, Espelosin Maria, Marcilla Irene, Perez-Mediavilla Alberto, Luquin Maria Rosario, Lanciego Jose Luis, Burrell Maria Angeles, Cuadrado-Tejedor Mar, Garcia-Osta Ana